CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML

Abroad (travel likely)RecruitingPHASE1

Conditions

Refractory Acute Myeloid Leukemia (AML) · Relapsed Acute Myeloid Leukemia (AML) · Myelodysplastic Syndrome · AML (Acute Myeloid Leukemia)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Mathew Angelos, MD, PhD

    Principal Investigator

    University of Colorado, Denver